NO981133D0 - Ikke-reseptormedierte kontrastmidler - Google Patents

Ikke-reseptormedierte kontrastmidler

Info

Publication number
NO981133D0
NO981133D0 NO981133A NO981133A NO981133D0 NO 981133 D0 NO981133 D0 NO 981133D0 NO 981133 A NO981133 A NO 981133A NO 981133 A NO981133 A NO 981133A NO 981133 D0 NO981133 D0 NO 981133D0
Authority
NO
Norway
Prior art keywords
receptor
contrast agents
mediated
mediated contrast
agents
Prior art date
Application number
NO981133A
Other languages
English (en)
Other versions
NO981133L (no
Inventor
Susan H Peers
Anne Goodbody
Alfred Pollak
John Thornback
Original Assignee
Resolution Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Resolution Pharm Inc filed Critical Resolution Pharm Inc
Publication of NO981133D0 publication Critical patent/NO981133D0/no
Publication of NO981133L publication Critical patent/NO981133L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
NO981133A 1995-09-15 1998-03-13 Ikke-reseptormedierte kontrastmidler NO981133L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/529,060 US5688489A (en) 1995-09-15 1995-09-15 Non-receptor mediated imaging agents
PCT/CA1996/000602 WO1997010266A1 (en) 1995-09-15 1996-09-09 Non-receptor mediated imaging agents

Publications (2)

Publication Number Publication Date
NO981133D0 true NO981133D0 (no) 1998-03-13
NO981133L NO981133L (no) 1998-05-13

Family

ID=24108346

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981133A NO981133L (no) 1995-09-15 1998-03-13 Ikke-reseptormedierte kontrastmidler

Country Status (8)

Country Link
US (2) US5688489A (no)
EP (1) EP0853632A1 (no)
JP (1) JPH11513363A (no)
AU (1) AU6867696A (no)
CA (1) CA2231352A1 (no)
IL (1) IL123606A0 (no)
NO (1) NO981133L (no)
WO (1) WO1997010266A1 (no)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents
US20030220258A1 (en) 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
EP1300418A1 (en) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Gene regulation by oligopeptides
US7358330B2 (en) * 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
FR2807523B1 (fr) * 2000-04-07 2002-08-30 Inst Nat Sante Rech Med UTILISATION D'UN RESTE PyA-(Z)x-pNF A DES FINS DE DETECTION, IDENTIFICATION ET/OU DOSAGE PAR FLUORESCENCE
GB2368339B (en) * 2000-10-26 2002-09-18 Yissum Res Dev Co Complex incorporating a plurality of antioxidants
US20030109457A1 (en) * 2001-10-25 2003-06-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress
DE10106852A1 (de) 2001-02-14 2002-09-05 T Luger Entzündungshemmende Verbindungen
US7528227B2 (en) * 2004-03-23 2009-05-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Histone H2A peptide derivatives and uses thereof
EP1432728A4 (en) * 2001-08-30 2007-10-24 Praecis Pharm Inc METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY DISORDERS
US7238671B2 (en) * 2001-10-18 2007-07-03 Bristol-Myers Squibb Company Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US7799757B2 (en) * 2002-06-13 2010-09-21 Michael Chorev Analogs of parathyroid hormone and PTH-related protein as bone anabolic agents
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
WO2005051982A1 (ja) * 2003-11-28 2005-06-09 Toagosei Co,. Ltd. 糖ペプチド及び温度応答性ミセル
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
EP2204383B1 (en) * 2004-04-08 2011-08-10 Millennium Pharmaceuticals, Inc. Processes for preparing eptifibatide and pertinent intermediate compounds
KR20070058463A (ko) * 2004-08-30 2007-06-08 도레이 가부시끼가이샤 분획 장치
ES2426441T3 (es) * 2004-10-18 2013-10-23 Basf Beauty Care Solutions France S.A.S. Oligopéptidos y su uso en cosméticos
US7563764B2 (en) * 2004-12-30 2009-07-21 E. I. Du Pont De Nemours And Company Antimicrobial peptides based on tripeptide repeats
NZ577196A (en) 2005-01-20 2011-06-30 Biomarck Pharmaceuticals Ltd Mucin hypersecretion inhibitors based on the structure of MANS and methods of use
WO2007004869A2 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
EP1782819A1 (en) * 2005-11-03 2007-05-09 Cognis IP Management GmbH Oligopeptides and their use
TWI303567B (en) * 2005-12-20 2008-12-01 Ind Tech Res Inst Oligopeptide, derivative thereof, and pharmaceutical composition comprising the same
US20100160207A1 (en) * 2006-02-16 2010-06-24 University Of Georgia Research Foundation, Inc. Feedback Prodrug
EP1987062B1 (en) * 2006-02-23 2011-06-22 Fibrex Medical Research & Development GmbH Peptides and peptide derivatives as well as pharmaceutical compositions containing the same
EP1864692A1 (en) * 2006-06-07 2007-12-12 Biotempt B.V. Use of peptides for the control of radiation injury
FR2900826B1 (fr) * 2006-05-12 2008-08-15 Soc Extraction Principes Actif Utilisation de peptides en tant que principes actifs amincissants.
CN103990111B (zh) * 2006-07-26 2016-08-31 拜欧马克医药有限公司 减少炎症介质释放的方法和可用于该方法的肽
US8691761B2 (en) * 2006-10-16 2014-04-08 Jean E. F. Rivier Somatostatin receptor 2 antagonists
CA2666642C (en) * 2006-10-16 2015-11-17 The Salk Institute For Biological Studies Receptor(sstr2)-selective somatostatin antagonists
JP5645408B2 (ja) * 2006-11-16 2014-12-24 カイ ファーマシューティカルズ インコーポレーティッド 副甲状腺機能亢進症および高カルシウム血症性障害の治療のためのポリカチオン性カルシウムモジュレーターペプチド
WO2008085828A2 (en) * 2007-01-03 2008-07-17 The Johns Hopkins University Peptide modulators of angiogenesis and use thereof
WO2008124698A2 (en) * 2007-04-06 2008-10-16 Kai Pharmaceuticals, Inc. Methods of use of gamma inhibitor compounds for the attenuation of pain
CA2730132A1 (en) * 2008-07-21 2010-01-28 Compugen Ltd. Novel angiopoietin derived peptides
WO2010048941A2 (de) * 2008-10-29 2010-05-06 Philipps-Universität Marburg N-terminal modifizierte tetrapeptidderivate mit c-terminalem argininmimetikum
FR2940969B1 (fr) * 2009-01-09 2012-05-04 Isp Investments Inc Nouveaux peptides anti-age et composition cosmetique et/ou pharmaceutique les contenant
ES2607954T3 (es) 2009-07-29 2017-04-04 Kai Pharmaceuticals, Inc. Agentes terapéuticos para reducir los niveles de hormona paratiroidea
JP2013511554A (ja) * 2009-11-23 2013-04-04 パラティン テクノロジーズ，インコーポレイテッド メラノコルチン−１受容体特異的線状ペプチド
US9073974B2 (en) * 2009-12-21 2015-07-07 The Regents Of The University Of California RGD-containing cyclic peptides
FR2956115B1 (fr) * 2010-02-05 2012-04-06 Isp Investments Inc Nouveaux peptides activateurs de la caspase-14 et compositions les comprenant
US9040660B2 (en) * 2010-04-20 2015-05-26 Novo Nordisk A/S Long-acting gastrin derivatives
EP2382963A1 (en) * 2010-04-29 2011-11-02 Cognis IP Management GmbH Cosmetic composition containing oligopeptides
EP2576594B1 (en) * 2010-05-30 2016-07-13 The Governing Council Of The University Of Toronto Mitochondrial penetrating peptides as carriers for antimicrobials
JP5943433B2 (ja) 2011-01-20 2016-07-05 ワンデイ − バイオテク アンド ファーマ リミテッド 抗酸化、抗炎症、抗放射線、金属キレート化合物およびその使用
FR2971784B1 (fr) * 2011-02-18 2015-01-02 Isp Investments Inc Nouveaux peptides activateurs de la synthese des proteines de la matrice extracellulaire et compositions cosmetiques les comprenant
WO2012123018A1 (en) * 2011-03-15 2012-09-20 Nanomed3D S.R.L. Functionalized biomaterials for tissue regeneration
LT2717896T (lt) 2011-06-08 2017-02-27 Kai Pharmaceuticals, Inc. Terapiniai agentai, skirti fosforo koncentracijos serume reguliavimui
KR101285259B1 (ko) * 2011-08-04 2013-07-11 (주)케어젠 Ｗｎｔ 계열 유래 펩타이드 및 이의 용도
JP2015505297A (ja) * 2011-10-28 2015-02-19 ルーイ・ジェイ・ユ Ｎ−アシルジペプチド誘導体およびその使用
ES2810153T3 (es) * 2012-03-01 2021-03-08 Novo Nordisk As Profármacos de GLP-1
US9618632B2 (en) * 2012-03-22 2017-04-11 Duke University Linear-response nanocrystal scintillators and methods of using the same
CN104717970A (zh) 2012-07-23 2015-06-17 万德-生物技术及制药有限公司 提高谷胱甘肽的组合物及其用途
EP2877194A4 (en) 2012-07-25 2016-03-16 Oneday Biotech And Pharma Ltd Compositions and methods for increasing carnitine concentration in muscle tissue
WO2014034754A1 (ja) * 2012-08-31 2014-03-06 塩野義製薬株式会社 Psf1由来ペプチド
CN104884078B (zh) * 2012-10-17 2017-06-20 诺和诺德股份有限公司 用于口服肽递送的脂肪酸酰化d‑氨基酸
KR20140088837A (ko) * 2013-01-03 2014-07-11 한미약품 주식회사 Ｎ-말단 전하가 변형된 인슐린 분비 펩티드 유도체
WO2014139182A1 (en) * 2013-03-15 2014-09-18 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof
US20140296164A1 (en) * 2013-03-29 2014-10-02 Calista Therapeutics, Inc. Compositions and methods of use for cell targeted inhibitors of the Cystic Fibrosis transmembrane regulator associated ligand
US10028999B2 (en) * 2014-05-11 2018-07-24 Tel Hashomer Medical Research Infrastructure And Services Ltd. PAR-1 based therapeutic conjugates and uses thereof
KR101470793B1 (ko) * 2014-06-30 2014-12-08 순천향대학교 산학협력단 흡수촉진제로서의 펩타이드와 이를 포함하는 조성물
WO2016129174A1 (ja) * 2015-02-09 2016-08-18 株式会社ファーマフーズ ヒアルロン酸産生促進剤
EP3118216A1 (en) 2015-07-16 2017-01-18 Nuritas Limited Cellular growth and proliferation promoting peptides, and uses thereof
KR102307260B1 (ko) 2015-07-16 2021-10-01 뉴리타스 리미티드 항염증 펩티드, 및 그의 용도
US9856302B2 (en) * 2015-07-23 2018-01-02 General Biologicals Corporation Anti-microbial peptide and method for treating microbial infection
EP3350200A4 (en) * 2015-09-18 2019-03-27 Wake Forest University Health Services ANGIOTENSIN ANALOGUES (1-7) AND ASSOCIATED METHODS
TWI619503B (zh) * 2015-12-14 2018-04-01 台灣基督長老教會馬偕醫療財團法人馬偕紀念醫院 短合成胜肽及其用途
WO2017152254A1 (en) * 2016-03-09 2017-09-14 Chu Sainte-Justine Methods for reducing perinatal morbidity and/or mortality
US10286038B2 (en) * 2016-03-11 2019-05-14 Northwestern University Lysosome membrane protein 2 (LIMP-2) based peptides and related uses
DK3454879T3 (da) * 2016-05-10 2022-03-14 Inst Nat Sante Rech Med Hidtil ukendte forbindelser og farmaceutisk anvendelse deraf i behandlingen af kræft
US10907212B2 (en) * 2016-05-14 2021-02-02 Regents Of The University Of Minnesota Inhibitors of cell adhesion
WO2017218355A1 (en) * 2016-06-15 2017-12-21 Counterpoint Biomedica Llc Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells
EP3503930A4 (en) 2016-08-29 2020-08-05 Fred Hutchinson Cancer Research Center CHELATING PLATFORM FOR DELIVERY OF RADIONUCLIDES
BR112019004203A2 (pt) * 2016-09-02 2019-06-25 Univ Illinois construto, composição farmacêutica, e, métodos para inibir angiogênese e para tratar uma doença ou enfermidade em um indivíduo distinguido por vascularização excessiva.
US10898544B2 (en) * 2016-12-13 2021-01-26 Emory University Polypeptides for managing viral infections
US11116817B2 (en) * 2017-02-17 2021-09-14 The Curators Of The University Of Missouri Antimicrobial agents and compositions comprising the same
US10570177B2 (en) * 2017-03-01 2020-02-25 The Chinese University Of Hong Kong P3 peptidylic inhibitors for treating CAG-repeat RNA toxicity in polyglutamine diseases
RU2678987C2 (ru) * 2017-04-28 2019-02-05 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Пептид для лечения болезни альцгеймера
EP3787661B1 (en) 2018-05-02 2023-10-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Combination of temozolomide and a par-1 conjugate for treating glioblastoma
KR102234027B1 (ko) * 2018-05-09 2021-03-31 서울대학교산학협력단 B형 간염 바이러스 유래 폴리펩티드 및 이의 항바이러스 용도
CN114437173A (zh) * 2019-01-07 2022-05-06 森纳生物科学公司 新型肽及其用途
US11685766B2 (en) 2019-05-08 2023-06-27 Creighton University 14-3-3 targeting peptides for cancer treatment
WO2020227625A1 (en) * 2019-05-08 2020-11-12 Laura Hansen 14-3-3 targeting peptides for cancer treatment
WO2021011283A1 (en) 2019-07-12 2021-01-21 Northwestern University Insulin like growth factor binding protein bioactive peptide fragments

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810777A (en) * 1987-03-04 1989-03-07 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial compounds
US5091514A (en) * 1987-03-26 1992-02-25 Neorx Corporation Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy
US5180816A (en) * 1988-08-24 1993-01-19 Centocor One vial method for labeling protein/linker conjugates with technetium-99M
US4962277A (en) * 1988-12-09 1990-10-09 Scripps Clinic And Research Foundation Deletion analogues of magainin peptides
WO1990011770A1 (en) * 1989-04-11 1990-10-18 Calgene, Inc. Use of animal-derived anti-microbial peptides for control of plant pathogens
US5585353A (en) * 1990-02-02 1996-12-17 The Rockefeller University Antibiotic peptides containing D-amino acids
US5043176A (en) * 1990-06-13 1991-08-27 Haarmann & Reimer Corp. Synergistic antimicrobial compositions
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
US5277892A (en) * 1990-08-08 1994-01-11 Rhomed Incorporated In vivo lymphocyte tagging
GB9118183D0 (en) * 1991-08-23 1991-10-09 Solanki Kishor K Imaging of infections
CA2125494A1 (en) * 1991-12-09 1993-06-24 Barry Berkowitz Composition and treatment with biologically active peptides and chelating agents
US5491074A (en) * 1993-04-01 1996-02-13 Affymax Technologies Nv Association peptides
US5582995A (en) * 1993-06-11 1996-12-10 The General Hospital Corporation Methods of screening for compounds which inhibit the direct binding of Ras to Raf
US5449761A (en) * 1993-09-28 1995-09-12 Cytogen Corporation Metal-binding targeted polypeptide constructs
US5480970A (en) * 1993-12-22 1996-01-02 Resolution Pharmaceuticals Metal chelators
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US5662885A (en) * 1994-07-22 1997-09-02 Resolution Pharmaceuticals Inc. Peptide derived radionuclide chelators
US5688489A (en) * 1995-09-15 1997-11-18 Resolution Pharmaceuticals, Inc. Non-receptor mediated imaging agents

Also Published As

Publication number Publication date
JPH11513363A (ja) 1999-11-16
EP0853632A1 (en) 1998-07-22
NO981133L (no) 1998-05-13
CA2231352A1 (en) 1997-03-20
US5837218A (en) 1998-11-17
US5688489A (en) 1997-11-18
IL123606A0 (en) 1998-10-30
AU6867696A (en) 1997-04-01
WO1997010266A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
NO981133D0 (no) Ikke-reseptormedierte kontrastmidler
DE69621528D1 (de) Anti-inflamatorische agenzien
DE69612617T2 (de) Chloridunterstützte hydrometallurgische metallextraktion
PT828506E (pt) Agentes endoparasiticidas
ATA135896A (de) Skibob
DE69616562T2 (de) Halbaxialgebläse
ATE198470T1 (de) Alkenyl-benzoylguanidine
DE69608334D1 (de) Cycloalkenyltetrazolinone
ITPI950018A0 (it) Vibrapack
FI950335A0 (fi) Hätäkutsulaite
ATE240972T1 (de) Cyclopeptolide
ATA119896A (de) Scheibenmähwerk
FI1893U1 (fi) Packningsstaell
FI1908U1 (fi) Maettningsanordning
FI2013U1 (fi) Slitytselement
FI2148U1 (fi) Solcell foer ruppvaermning
FI2156U1 (fi) Traestolpe
FI2160U1 (fi) Staellning
FI2198U1 (fi) Redskap foer staedning utomhus
FI2219U1 (fi) Flaskstaellning
KR960030307U (ko) 다시
BR7500991U (pt) Caríndio
FIU950124U0 (fi) Postlaodsystem
FI950846A0 (fi) Oeppningsverktyg foer Abloy-laos
BR7500838U (pt) Vassourágua